Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Fluoride in preterm infant formula unacceptable for safety issues, coalition advises.

This article was originally published in The Tan Sheet

Executive Summary

PRETERM INFANT FORMULA SUPPLEMENTAL FLUORIDE INCLUSION DISCOURAGED by the New York State Coalition Opposed to Fluoridation in June 22 comments to FDA and the Federation of American Societies for Experimental Biology Life Sciences Research Office. Pointing to potential health risks involving excessive fluoride intake in children, the coalition of individuals, health professionals, law makers and community groups questions whether "any consideration at all should be given to exposing low birth-weight, premature infants to fluoride, in any form or in any amount, no matter how low."
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS088645

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel